share_log

华康生物医学(08622)公布2023年业绩 净亏损578.2万元 同比扩大88%

Huakang Biomedical (08622) announced 2023 results, net loss of 5.782 million yuan, an increase of 88% year-on-year

Zhitong Finance ·  Mar 29 09:21

Huakang Biomedical (08622) announced its 2023 results, with revenue of 246.29 million yuan, a year-on-year decrease of 2.8...

According to the Zhitong Finance App, Huakang Biomedical (08622) announced its 2023 results, with revenue of 24.6.29 million yuan, a year-on-year decrease of 2.8%; net loss of 5.782 million yuan, an increase of 88% over the previous year; and a loss of 1.39 points per share.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment